- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Austin Frakt on the Problem of Corporate Wellness Programs
The biggest problem with corporate wellness programs is that they are not as effective as they are claimed they will be, according Austin Frakt, PhD, health economist and researcher and the primary author of The Incidental Economist.
The biggest problem with corporate wellness programs is that they are not as effective as they are claimed they will be, Austin Frakt, PhD, health economist and researcher and the primary author of The Incidental Economist, said at America's Health Insurance Plans' National Health Policy Conference in Washington, DC, March 11-12.
Part of the reason why these programs haven't been able to improve health and lower costs is because they aren't being targeted properly to where healthcare costs are and who can benefit from different types of care. Not all wellness programs have performed poorly, though. Those programs that focus on disease management and preventive care have better outcomes, he said.
"Preventive care doesn't always save money, but for people who have chronic conditions, who are legitimately very sick, it does in those cases," Dr Frakt said. "So that's where you want to focus your efforts."
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
